Browse the evidence

Gamification with support significantly increased mean daily steps by 503 steps compared to the control group over 1 year.

Incorporating gamification with support can effectively enhance physical activity in patients with uncontrolled diabetes.

Gamification with competition significantly increased mean daily steps by 606 steps compared to the control group over 1 year.

Utilizing gamification with competitive elements can effectively boost physical activity in patients with uncontrolled diabetes.

Endoscopic sleeve gastroplasty (ESG) added 0.06 quality-adjusted life-years (QALYs) and reduced total cost by $33,583 relative to semaglutide.

This indicates that ESG not only provides health benefits but also reduces overall treatment costs.

Effective weight management requires a physician-patient partnership.

Physicians should focus on building supportive relationships with patients to improve weight management outcomes.

Physicians should evaluate a patient's readiness to change and set appropriate weight-loss goals.

Physicians should assess patients' readiness for change and collaboratively set realistic weight-loss goals.

Diet quality changes are associated with long-term weight gain.

Focus on improving diet quality rather than just calorie counting.

The experimental group significantly increased their intake of fruits and vegetables and cooking with monounsaturated fat compared to the control group at 1 year.

Group office visits can effectively enhance dietary habits in CAD patients.

Dietary adherence is good when all foods are provided and when participants are highly motivated.

Providing all foods and ensuring participant motivation can enhance adherence to dietary interventions.

Restriction of carbohydrate to 50–130 g per day had beneficial effects on HbA1c in trials up to 6 months.

Low-carbohydrate diets may be beneficial for glycaemic control in the short term for Type 2 diabetes.

A target of 10–15% weight loss is recommended for people with BMI 30–40 kg/m2 or abdominal obesity without complications.

Practitioners should aim for a 10-15% weight loss in this patient group.

For people with BMI 30–40 kg/m2 or abdominal obesity and complications, a weight loss target of 10–15% body weight is recommended.

Practitioners should target a 10-15% weight loss for this patient group.

A weight loss target of > 15% is recommended for those with BMI > 40 kg/m2 and complications.

Practitioners should aim for more than 15% weight loss in this patient group and consider referral to specialists.

If all eligible individuals received medically tailored meals (MTMs), an estimated 1,594,000 hospitalizations could potentially be averted in 1 year.

Healthcare providers should consider the potential benefits of MTMs in reducing hospitalizations for eligible patients.

Current therapy interventions for NAFLD are mainly focused on progressive weight loss through modulation of overall calorie intake with or without specific macronutrient adjustments.

Practitioners should focus on calorie intake modulation for weight loss in NAFLD management.

Liquid meal replacements in weight loss diets lead to a mean reduction in body weight of −2.37 kg (95% CI −3.30 to −1.44).

Incorporating liquid meal replacements can aid in weight loss for individuals with type 2 diabetes.

Sitting for 2.5 hours less each day could result in an extra energy expenditure of 350 kcal/day.

Reducing sitting time may help in weight management strategies.

Roux-en-Y gastric bypass surgery resulted in a greater percentage of excess weight loss compared to medical management, with 66% versus -1.6%.

Practitioners can expect significant weight loss in patients undergoing gastric bypass surgery compared to those managed medically.

Participants in the intensive lifestyle intervention (ILI) engaged in significantly more bout-related moderate-to-vigorous-intensity physical activity (MVPA) compared to the Diabetes Support and Education (DSE) group at year 1 (151.0 ± 213.5 vs 87.5 ± 145.1 min·wk, P < 0.0001) and year 4 (102.9 ± 195.6 vs 73.9 ± 267.5 min·wk, P < 0.001).

Implementing intensive lifestyle interventions can significantly increase physical activity levels in older adults with type 2 diabetes.

More ILI participants achieved ≥175 min·wk of MVPA at year 1 (29.1% vs 16.3%, P < 0.001) and year 4 (18.3% vs 10.0%, P < 0.001) compared to DSE participants.

Targeting a specific MVPA goal can lead to higher achievement rates in older adults with type 2 diabetes.

The low-carbohydrate diet (LCD) arm lost an average of 12.3 kg compared to a loss of 0.60 kg in the control arm (P < 0.001).

Implementing a low-carbohydrate diet may significantly aid in weight loss for men with recurrent prostate cancer.

Mean percentage weight change at 1 year was -5.1% with semaglutide compared to -2.2% with liraglutide (P < .001).

Semaglutide may be more effective than liraglutide for weight loss in clinical practice.

Weight change at 6 months was -4.31% for the standardized group and -3.26% for the personalized group.

Both diet approaches resulted in weight loss, but the standardized low-fat diet was more effective.

Tirzepatide facilitated an average 18.5% weight loss (>46 pounds) in overweight and obese patients with type 1 diabetes at 1 year.

Practitioners may consider tirzepatide as an effective option for weight management in this patient population.

Total body carbohydrate stores are often less than the carbohydrate requirements of athletic training and competition.

Athletes should monitor carbohydrate intake to meet training and competition demands.